Actuate Therapeutics, Inc. (ACTU) SEC Filings — 2025
17 SEC filings for Actuate Therapeutics, Inc. (ACTU) in 2025.
Filings
- Actuate Therapeutics Files 8-K — 8-K · Nov 28, 2025
- Actuate Therapeutics, Inc. 8-K Filing — 8-K · Nov 21, 2025
- Actuate Narrows Losses Amid R&D Cuts, Fresh Capital Influx — 10-Q · Nov 13, 2025
- Actuate Therapeutics Enters Material Definitive Agreement — 8-K · Sep 10, 2025
- Actuate Narrows Q2 Loss, R&D Plummets Amid Cash Burn Concerns — 10-Q · Aug 14, 2025
- Actuate Therapeutics Files S-1 for Public Offering — S-1 · Jul 25, 2025
- Actuate Therapeutics Enters Material Agreement, Files 8-K — 8-K · Jun 26, 2025
- Actuate Therapeutics Files 8-K — 8-K · Jun 5, 2025
- Actuate Therapeutics Files 8-K — 8-K · Jun 2, 2025
- Actuate Therapeutics Files 8-K on Security Holder Vote — 8-K · May 23, 2025
- Actuate Therapeutics Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Actuate Therapeutics Files 8-K — 8-K · May 6, 2025
- Actuate Therapeutics Files Proxy Materials — DEFA14A · Apr 9, 2025
- Actuate Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 8, 2025
- Actuate Therapeutics Files 8-K for Material Agreement — 8-K · Mar 28, 2025
- Actuate Therapeutics Files 2024 10-K — 10-K · Mar 13, 2025
- Actuate Therapeutics to be Acquired by 03 Life Sciences — 8-K · Feb 7, 2025